Repatha

Evolocumab (genetical recombination)

Approval Information

Brand NameRepatha
Generic NameEvolocumab (genetical recombination)
ApprovedJanuary 2016
TypeInitial Approval

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.